Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Ottawa

$105,000.00

The role of phophatidylinositol 4 kinase III beta (PI4KIIIbeta) in cytoskeleton remodeling, AKT activation and cell motility

EF 2008-09

Résumé
My research focuses on PI4KIIIbeta, a protein that acts on lipids, a component of fats, in the cell. This protein is activated by a breast cancer oncogene, the eukaryotic elongation factor 1 alpha 2 (eEF1A2). An oncogene is a protein which when found in greater quantity in the cell than normal is linked to the development of cancer. Normal cells become cancer cells through an increase in survival signals and a shut down of death signals. The structural framework of the cell is also altered, which leads to cell migration, allowing clumping of cancerous cells, leading to tumor formation. We have found that eEF1A2 activates cell survival signaling, reorganizes cell structure and increases cell migration. We believe that it is through PI4KIIIbeta that eEF1A2 is affecting these changes in the cell. To date, I have found that PI4KIIIbeta is involved in the activation of survival signals in the cell and has the capacity to alter the cell's structure. My future work will be to determine a role for PI4KIIIbeta in cell movement and migration. I will be looking at how increased or decreased PI4KIIIbeta protein levels affect cell migration. I will also be looking at the distribution of lipids altered by PI4KIIIbeta in a moving cell to understand how PI4KIIIbeta may be affecting cell migration. Fundamentally, the goal of my project is to determine at the molecular level what contributes to the development of breast cancer.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
184665
Name
Morrow Anne A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The role of phophatidylinositol 4 kinase III beta (PI4KIIIbeta) in cytoskeleton remodeling, AKT activation and cell motility
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Breast Cancer; Cell Motility; Cell Work; Cloning; Cytoskeleton Remodeling; Immunofluorescence; Phosphatidylinositol; Pi4kiiibeta; Sirna; Transfection/Infection
Abstract
My research focuses on PI4KIIIbeta, a protein that acts on lipids, a component of fats, in the cell. This protein is activated by a breast cancer oncogene, the eukaryotic elongation factor 1 alpha 2 (eEF1A2). An oncogene is a protein which when found in greater quantity in the cell than normal is linked to the development of cancer. Normal cells become cancer cells through an increase in survival signals and a shut down of death signals. The structural framework of the cell is also altered, which leads to cell migration, allowing clumping of cancerous cells, leading to tumor formation. We have found that eEF1A2 activates cell survival signaling, reorganizes cell structure and increases cell migration. We believe that it is through PI4KIIIbeta that eEF1A2 is affecting these changes in the cell. To date, I have found that PI4KIIIbeta is involved in the activation of survival signals in the cell and has the capacity to alter the cell's structure. My future work will be to determine a role for PI4KIIIbeta in cell movement and migration. I will be looking at how increased or decreased PI4KIIIbeta protein levels affect cell migration. I will also be looking at the distribution of lipids altered by PI4KIIIbeta in a moving cell to understand how PI4KIIIbeta may be affecting cell migration. Fundamentally, the goal of my project is to determine at the molecular level what contributes to the development of breast cancer.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Morrow, Anne A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~